Carriers of GSTM1*0 genotype have detoxification deficiencies which have been associated with the risk of developing several malignant neoplasias including as GC 12-14.
Los portadores del genotipo GSTM1*0 presentan deficiencias desintoxicadoras y se ha asociado con el riesgo a desarrollar varias neoplasias malignas, entre ellas el CG 12-14.